D
Deepali Kumar
Researcher at University Health Network
Publications - 149
Citations - 5184
Deepali Kumar is an academic researcher from University Health Network. The author has contributed to research in topics: Transplantation & Viral load. The author has an hindex of 35, co-authored 147 publications receiving 3526 citations. Previous affiliations of Deepali Kumar include Toronto General Hospital & University of Toronto.
Papers
More filters
Journal ArticleDOI
Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients.
Victoria G Hall,Victor H Ferreira,Terrance Ku,Matthew Ierullo,Beata Majchrzak-Kita,C. Chaparro,Nazia Selzner,Jeffrey Schiff,Michael McDonald,George Tomlinson,Vathany Kulasingam,Deepali Kumar,Atul Humar +12 more
TL;DR: A Third Vaccine Dose in Organ-Transplant Recipients It is known that people receiving immune suppressive therapy, such as recipients of solid-organ transplants, have a suboptimal response to SARS-C...
Journal ArticleDOI
KDIGO Clinical Practice Guideline on the evaluation and management of candidates for kidney transplantation
Steven J. Chadban,Curie Ahn,David A. Axelrod,Bethany J. Foster,Bertram L. Kasiske,Vijah Kher,Deepali Kumar,Rainer Oberbauer,Julio Pascual,Helen Pilmore,James R. Rodrigue,Dorry L. Segev,Neil S. Sheerin,Kathryn Tinckam,Germaine Wong,Gregory A. Knoll +15 more
TL;DR: The goal is to assist the clinical team to assimilate all data relevant to an individual, consider this within their local health context, and make an overall judgment on candidacy for transplantation.
Journal ArticleDOI
Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial.
Jordan J. Feld,Jordan J. Feld,Christopher Kandel,Mia J. Biondi,Mia J. Biondi,Robert A. Kozak,Muhammad Atif Zahoor,Muhammad Atif Zahoor,Camille Lemieux,Sergio Borgia,Andrea K. Boggild,Jeff Powis,Janine McCready,Darrell H. S. Tan,Tiffany Chan,Bryan Coburn,Deepali Kumar,Atul Humar,Adrienne K. Chan,Braden O’Neil,Seham Noureldin,Seham Noureldin,Joshua Booth,Joshua Booth,Rachel Hong,Rachel Hong,David Smookler,David Smookler,Wesam Aleyadeh,Wesam Aleyadeh,Anjali Patel,Anjali Patel,Bethany Barber,Bethany Barber,Julia Casey,Julia Casey,Ryan Hiebert,Henna Mistry,Ingrid Choong,Colin Hislop,Deanna M. Santer,D. Lorne Tyrrell,Jeffrey S. Glenn,Adam J. Gehring,Adam J. Gehring,Harry L.A. Janssen,Harry L.A. Janssen,Bettina E. Hansen,Bettina E. Hansen +48 more
TL;DR: In this paper, the safety and efficacy of peginterferon lambda in the treatment of outpatients with mild-to-moderate COVID-19 was investigated in a double-blind, placebo-controlled trial.
Journal ArticleDOI
Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia.
TL;DR: CMI assessment shortly after the onset of CMV viremia may be useful to predict progression versus spontaneous viral clearance, thereby helping guide the need for antiviral therapy and refining current preemptive strategies.
Journal ArticleDOI
A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients.
Deepali Kumar,Victor H Ferreira,Emily A. Blumberg,Fernanda P. Silveira,Elisa Cordero,Pilar Pérez-Romero,Teresa Aydillo,Lara Danziger-Isakov,Ajit P. Limaye,Jordi Carratalà,Patricia Muñoz,Miguel Montejo,Francisco López-Medrano,María Carmen Fariñas,Joan Gavaldà,Asunción Moreno,Marilyn E. Levi,Jesús Fortún,Julián Torre-Cisneros,Janet A. Englund,Yoichiro Natori,Shahid Husain,Gail E. Reid,Tanvi Sharma,Atul Humar +24 more
TL;DR: Annual influenza vaccination and early antiviral therapy are associated with a significant reduction in influenza-associated morbidity, and should be emphasized as strategies to improve outcomes of transplant recipients.